Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo
- 1 November 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 157 (1) , 83-91
- https://doi.org/10.1016/0014-2999(88)90474-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human plateletsThrombosis Research, 1987
- Endothelium‐derived relaxing factor inhibits in vitro platelet aggregationBritish Journal of Pharmacology, 1987
- Characterization of vascular relaxant factor released from cultured endothelial cells.Hypertension, 1987
- Attenuation of endothelium-dependent relaxation in aorta from diabetic ratsEuropean Journal of Pharmacology, 1986
- A minimally invasive technique for the study of intravascular platelet aggregation in anesthetized ratsJournal of Pharmacological Methods, 1986
- The loss of endothelium-dependent vascular relaxation in hypertension.Hypertension, 1986
- Endothelium‐dependent inhibition of platelet aggregationBritish Journal of Pharmacology, 1986
- Identification of 6‐oxo‐prostaglandin E1 as a naturally occurring prostanoid generated by rat lungBritish Journal of Pharmacology, 1986
- A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea‐pigs and ratsBritish Journal of Pharmacology, 1985
- Role of endothelium in responses of vascular smooth muscle.Circulation Research, 1983